Bispecifics in Multiple Myeloma: Adverse Event Management :

Expert perspectives on adverse event management in patients on bispecific therapy for multiply relapsed multiple myeloma.

Related Keywords

, Evolving Treatment Paradigm , Multiple Myeloma , Recent Updates , Adverse Event Management , Myeloma Cancer , Relapsed Refractory Multiple Myeloma , Multiply Relapsed , Later Line Treatment , Later Line Therapy , Adverse Events , Drug Adverse Event , Crs , Cytokine Release Syndrome , Pelicans , Immune Effector Cell Associated Neurotoxicity Syndrome , Prophylaxis , Prophylactic Treatment , Tocilizumab , Asco 2023 , Asco Annual Meeting ,